Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure
- 31 December 1993
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 17 (2), 220-226
- https://doi.org/10.1016/s0168-8278(05)80042-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of Inhibitors of Prostaglandin Synthesis On Induced Diuresis in CirrhosisHepatology, 2007
- Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administrationJournal of Hepatology, 1990
- Effects of PGE2 Infusion on Renal Function in Normal Man before and after Angiotensin II Inhibition by CaptoprilKidney and Blood Pressure Research, 1987
- Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites: Relationship to functional renal failure (hepatorenal syndrome)Journal of Hepatology, 1986
- Urinary Prostaglandins and Renal Function in Chronic Liver DiseasesScandinavian Journal of Gastroenterology, 1986
- Chemistry and synthetic development of misoprostolDigestive Diseases and Sciences, 1985
- Overview of clinical safety with misoprostolDigestive Diseases and Sciences, 1985
- Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosisKidney International, 1984
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977